330 related articles for article (PubMed ID: 22072438)
1. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
2. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review.
Marchesi F; Annibali O; Cerchiara E; Tirindelli MC; Avvisati G
Crit Rev Oncol Hematol; 2011 Dec; 80(3):331-46. PubMed ID: 21123080
[TBL] [Abstract][Full Text] [Related]
4. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
[TBL] [Abstract][Full Text] [Related]
6. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
7. [Pathobiology of acute myeloid leukemia].
Christ O; Feuring-Buske M; Hiddemann W; Buske C
Med Klin (Munich); 2007 Apr; 102(4):290-5. PubMed ID: 17426932
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.
von Neuhoff C; Reinhardt D; Sander A; Zimmermann M; Bradtke J; Betts DR; Zemanova Z; Stary J; Bourquin JP; Haas OA; Dworzak MN; Creutzig U
J Clin Oncol; 2010 Jun; 28(16):2682-9. PubMed ID: 20439630
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetics in acute leukemia.
Mrózek K; Heerema NA; Bloomfield CD
Blood Rev; 2004 Jun; 18(2):115-36. PubMed ID: 15010150
[TBL] [Abstract][Full Text] [Related]
10. Unfavorable-risk cytogenetics in acute myeloid leukemia.
Hong WJ; Medeiros BC
Expert Rev Hematol; 2011 Apr; 4(2):173-84. PubMed ID: 21495927
[TBL] [Abstract][Full Text] [Related]
11. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
[TBL] [Abstract][Full Text] [Related]
13. Dominant and opportunistic leukemic clones: proposal for a pathogenesis-oriented classification in acute myeloid leukemia.
Cucuianu A
Med Hypotheses; 2005; 65(1):107-13. PubMed ID: 15893127
[TBL] [Abstract][Full Text] [Related]
14. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics of pediatric acute myeloid leukemia.
Manola KN
Eur J Haematol; 2009 Nov; 83(5):391-405. PubMed ID: 19563518
[TBL] [Abstract][Full Text] [Related]
16. Platelet production and related pathophysiology in acute myelogenous leukemia at first diagnosis: prognostic implications.
Trafalis DT; Poulakidas E; Kapsimali V; Tsigris C; Papanicolaou X; Harhalakis N; Nikiforakis E; Mentzikof-Mitsouli C
Oncol Rep; 2008 Apr; 19(4):1021-6. PubMed ID: 18357391
[TBL] [Abstract][Full Text] [Related]
17. Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.
Cilloni D; Renneville A; Hermitte F; Hills RK; Daly S; Jovanovic JV; Gottardi E; Fava M; Schnittger S; Weiss T; Izzo B; Nomdedeu J; van der Heijden A; van der Reijden BA; Jansen JH; van der Velden VH; Ommen H; Preudhomme C; Saglio G; Grimwade D
J Clin Oncol; 2009 Nov; 27(31):5195-201. PubMed ID: 19752335
[TBL] [Abstract][Full Text] [Related]
18. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
Larson RA
Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
[TBL] [Abstract][Full Text] [Related]
19. What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working Parties.
Grimwade D; Walker H; Oliver F; Wheatley K; Clack R; Burnett A; Goldstone A
Bone Marrow Transplant; 1997 Jun; 19(11):1117-23. PubMed ID: 9193755
[TBL] [Abstract][Full Text] [Related]
20. Genetic classification of acute myeloid leukemia (AML).
Haferlach T; Schnittger S; Kern W; Hiddemann W; Schoch C
Ann Hematol; 2004; 83 Suppl 1():S97-100. PubMed ID: 15124693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]